References
- 1. H. Frankish, 15 Million new cancer cases per year by 2020, says WHO, Lancet361 (2003) 1278–1287; DOI: 10.1016/S0140-6736(03)13038-3.10.1016/S0140-6736(03)13038-3
- 2. K. Kubo, T. Shimizu, S. I. Ohyama, H. Murooka, A. Iwai, K. Nakamura, K. Hasegawa, Y. Kobayashi, N. Takahashi, K. Takahashi, S. Kato, T. Izawa and T. Isoe, Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N’-{4-(4-quinolyloxy)phenyl}-ureas, J. Med. Chem. 48 (2005) 1359–1366; DOI: 10.1021/jm030427r.10.1021/jm030427r
- 3. R. O’Connor, Mdm–mediated ubiquitylation: P53 and beyond, a review of mechanisms of circumvention and modulation of chemotherapeutic drug resistance, Curr. Cancer Drug Targets9 (2009) 273–280; DOI: 10.2174/156800909788166583.10.2174/156800909788166583
- 4. C. Hu, V. R Solomon and G. L. Ulibarri, The efficacy and selectivity of tumor cell killing by AKT inhibitors are substantially increased by chloroquin, Bioorg. Med. Chem. 16 (2008) 7888–7893; DOI: 10.1016/j.bmc.2008.07.076.10.1016/j.bmc.2008.07.076
- 5. Y. C. Mayur, G. J. Peters, V. V. Prasad, C. Lemo and N. K. Sathish, Design of new drug molecules to be used in reversing multidrug resistance in cancer, Curr. Cancer Drug Targets9 (2009) 298–306; DOI: 10.2174/156800909788166619.10.2174/156800909788166619
- 6. M. G. Ferlin, B. Gatto, G. Chiarelotto and M. Palumbo, Pyrroloquinoline derivatives as potential antineoplastic drugs, Bioorg. Med. Chem.8 (2000) 1415–1422; DOI: 10.1016/S0968-0896(00)00060-2.10.1016/S0968-0896(00)00060-2
- 7. M. S. Alsaid, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem.46 (2011) 137–141; DOI: 10.1016/j.ejmech.2010.10.024.10.1016/j.ejmech.2010.10.024
- 8. S. Pédeboscq, D. Gravier, F. Casadebaig, G. Hou, A. Gissot, F. De. Giorgi, F. Ichas, J. Cambar and J. P. Pometan, Synthesis and study of antiproliferative activity of novel thienopyrimidines on glioblastoma cells, Eur. J. Med. Chem.45 (2010) 2473–2479; DOI:10.1016/j.ejmech.-2010.02.032.
- 9. R. L. Weinkauf, A. Y. Chen, C. Yu, L. Liu, L. Barrows and E. J. LaVoie, Antineoplastic activity of benzimidazo[1,2-b] isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles, Bioorg. Med. Chem.2 (1994) 781–786; DOI: 10.1016/S0968-0896(00)82177-X.10.1016/S0968-0896(00)82177-X
- 10. S. Li, Z. Yao, Y. Zhao, W. Chen, H. Wang, X. Kuang, W. Zhan, S. Yao, S. Yu and W. Hu, Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase, Bioorg. Med. Chem. Lett. 22 (2012) 5279–5282; DOI: 10.1016/j.bmcl.2012.06.044.10.1016/j.bmcl.2012.06.04422789429
- 11. F. E. Onen-Bayram, I. Durmaz, D. Scherman, J. Herscovici and R. Cetin-Atalay, A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells, Bioorg. Med. Chem.20 (2012) 5094–5102; DOI: 10.1016/j.bmc.2012.07.016.10.1016/j.bmc.2012.07.01622867707
- 12. G. J. Atwell, C. D. Bos, B. C. Baguley and W. A. Denny, Potential antitumor agents. 56. “Minimal” DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides, J. Med. Chem. 3 (1988) 1048–1052; DOI: 10.1021/jm00400a029.10.1021/jm00400a029
- 13. G. J. Atwell, B. C. Baguley and W. A. Denny, Potential antitumor agents. 57. 2-phenylquinoline-8-carboxamides as minimal DNA-intercalating antitumor agents with in vivo solid tumor activity, J. Med. Chem. 32 (1989) 396–401; DOI: 10.1021/jm00122a018.10.1021/jm00122a018
- 14. T. Suzuki, N. Fukazawa, K. San-nohe, W. Sato, O. Yano and T. Tsuruo, Structure activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer, J. Med. Chem. 40 (1997) 2047–2052; DOI: 10.1021/jm960869l.10.1021/jm960869l
- 15. Y. H. Wang, T. Motoji, S. Motomura, N. Shiozaki, T. Tsuruo and H. Mizoguchi, Multi-drug resistance-reversing agent, on acute myelogenous leukaemic blasts and K562 cells resistant to adriamycin cell line, Eur. J. Haematol. 58 (1997) 186–194; DOI: 10.1111/j.1600-0609.1997.tb00946.x.10.1111/j.1600-0609.1997.tb00946.x
- 16. H. Zhao, Y. Cai, S. Santi, R. Lafrenie and H. Lee, Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis, Radiat. Res. 164 (2005) 250–257; DOI: 10.1667/RR3436.1.10.1667/RR3436.1
- 17. H. Zhang, V. R. Solomon, C. Hu, G. Ulibarri and H. Lee, Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives, Biomed. Pharmacother.62 (2008) 65–69; DOI: 10.1016/j.biopha.2007.04.007.10.1016/j.biopha.2007.04.007
- 18. V. R. Solomon and H. Lee, Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies, Eur. J. Pharmacol. 625 (2009) 220–233; DOI: 10.1016/j.ejphar.2009.06.063.10.1016/j.ejphar.2009.06.063
- 19. M. S. Al-Said, M. G. El-Gazzar, M. S. Al-Dosari and M. M. Ghorab, Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives, Arzneimittel-Forsch.62 (2012) 149–156; DOI: 10.1055/s-0031-1299695.10.1055/s-0031-1299695
- 20. P. Fossa, G. Menozzi, P. Dorigo, M. Floreani and L. Mosti, Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone, Bioorg. Med. Chem.11 (2003) 4749–4759; DOI: 10.1016/S0968-0896(03)00528-5.10.1016/S0968-0896(03)00528-5
- 21. W. Chen, P. Zhan, D. Rai, E. De Clercq, C. Pannecouque, J. Balzarini, Z. Zhou, H. Liu and X. Liu, Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays, Bioorg. Med. Chem.22 (2014) 1863–1872; DOI: 10.1016/j.bmc.2014.01.054.10.1016/j.bmc.2014.01.05424581546
- 22. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660–670; DOI: 10.1007/s12272-013-0094-6.10.1007/s12272-013-0094-623529860
- 23. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50–58; DOI: 10.1248/cpb.c12-00812.10.1248/cpb.c12-0081223302586
- 24. M. S. Alsaid, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneimittel-Forsch. 61 (2011) 527–531; DOI: 10.1055/s-0031-1296239.10.1055/s-0031-129623922029230
- 25. M. S. Bashandy, M. S. Al-Said, S. I. Al-Qasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1, 2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity, Arzneimittel-Forsch. 61 (2011) 521–526; DOI: 10.1055/s-0031-1296238.10.1055/s-0031-129623822029229
- 26. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocycl. Chem.48 (2011) 563–571; DOI: 10.1002/jhet.619.10.1002/jhet.619
- 27. M. S. Al-Said, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137–141; DOI: 10.1016/j.ejm-ech.2010.10.024.
- 28. M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res.20 (2011) 388–400; DOI: 10.1007/s00044-010-9332-3.10.1007/s00044-010-9332-3
- 29. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer. Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.10.1093/jnci/82.13.11072359136
- 30. M. M. Ghorab, M. S. Alsaid, H. A. Ghabour and H.-K. Fun, Synthesis, crystal structure and antitumor activity of novel 2-cyano-N-(quinolin-3-yl) acetamide, Asian J. Chem. 26 (2014) 7389–7392; DOI:10.14233/ajchem.2014.17050.10.14233/ajchem.2014.17050